NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000527

Registered date:22/11/2006

Randomized trial to evaluate the renoprotective effect of cilostazol on chronic kidney disease patients with arteriosclerosis obliterans

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedChronic kidney disease
Date of first enrollment2006/12/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Cilostazol 100mg and Aspirin 100mg daily Aspirin 100mg daily

Outcome(s)

Primary OutcomeChange in glomerular filtration rate and renal plasma flow
Secondary OutcomeChange in pulse wave velocity and von Willebrand factor Occurrence of cardiovascular event

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients with allergy for cilostazol or aspirin, bleeding tendency, or pregnancy. Patients with other platelet aggregation inhibitor or anticoagulant drug. Patients who are inadequate to entry this study by physicians in charge.

Related Information

Contact

public contact
Name Chie Saito
Address 1-1-1,Ten-nodai,Tsukuba,Ibaraki Japan
Telephone 029-853-3202
E-mail kidney@md.tsukuba.ac.jp
Affiliation Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences,University of Tsukub Division of Nephrology
scientific contact
Name Kunihiro Yamagata
Address 1-1-1,Ten-nodai,Tsukuba,Ibaraki Japan
Telephone 029-853-3202
E-mail
Affiliation Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences,University of Tsukuba Division of Nephrology